Literature DB >> 26243361

Bone histomorphometry in diabetes mellitus.

C A Moreira1,2, D W Dempster3,4.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26243361     DOI: 10.1007/s00198-015-3258-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  20 in total

1.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  FRAX underestimates fracture risk in patients with diabetes.

Authors:  Lora M Giangregorio; William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

3.  Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.

Authors:  Antonia García-Martín; Pedro Rozas-Moreno; Rebeca Reyes-García; Sonia Morales-Santana; Beatriz García-Fontana; José A García-Salcedo; Manuel Muñoz-Torres
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

4.  [Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID)].

Authors:  M E Leite Duarte; R D da Silva
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1996 Jan-Feb

5.  Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.

Authors:  Elsa S Strotmeyer; Jane A Cauley; Trevor J Orchard; Ann R Steenkiste; Janice S Dorman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

6.  Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Kiyoko Nawata; Mika Yamauchi; Toshitsugu Sugimoto
Journal:  J Clin Endocrinol Metab       Date:  2012-02-15       Impact factor: 5.958

7.  Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.

Authors:  Agostino Gaudio; Filippo Privitera; Katia Battaglia; Venerando Torrisi; Maria Helga Sidoti; Ivana Pulvirenti; Elena Canzonieri; Giovanni Tringali; Carmelo Erio Fiore
Journal:  J Clin Endocrinol Metab       Date:  2012-08-01       Impact factor: 5.958

8.  Bone loss and bone turnover in diabetes.

Authors:  J C Krakauer; M J McKenna; N F Buderer; D S Rao; F W Whitehouse; A M Parfitt
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

9.  Diabetes-related complications, glycemic control, and falls in older adults.

Authors:  Ann V Schwartz; Eric Vittinghoff; Deborah E Sellmeyer; Kenneth R Feingold; Nathalie de Rekeneire; Elsa S Strotmeyer; Ronald I Shorr; Aaron I Vinik; Michelle C Odden; Seok Won Park; Kimberly A Faulkner; Tamara B Harris
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

10.  Young women with type 1 diabetes have lower bone mineral density that persists over time.

Authors:  Lucy D Mastrandrea; Jean Wactawski-Wende; Richard P Donahue; Kathleen M Hovey; Angela Clark; Teresa Quattrin
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

View more
  3 in total

1.  Imaging of diabetic bone.

Authors:  Federico Ponti; Sara Guerri; Claudia Sassi; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi
Journal:  Endocrine       Date:  2017-03-14       Impact factor: 3.633

2.  Hip Fracture Risk According to Diabetic Kidney Disease Phenotype in a Korean Population.

Authors:  Seung Eun Lee; Juhwan Yoo; Kyoung-Ah Kim; Kyungdo Han; Han Seok Choi
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28

Review 3.  The impact of type 2 diabetes on bone metabolism.

Authors:  Claudia Pinheiro Sanches; Andre Gustavo Daher Vianna; Fellype de Carvalho Barreto
Journal:  Diabetol Metab Syndr       Date:  2017-10-19       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.